Article Information
History
- June 7, 2021.
Article Versions
- Version 1 (February 23, 2021 - 07:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Divya V. Israni1,*,
- Hui-Shan Li1,*,
- Keith A. Gagnon1,
- Jeffry D. Sander2,3,4,
- Kole T. Roybal5,6,7,8,
- J. Keith Joung2,3,
- Wilson W. Wong1 and
- Ahmad S. Khalil1,9,†
- 1Department of Biomedical Engineering and Biological Design Center, Boston University, Boston, MA 02215, USA
- 2Molecular Pathology Unit, Center for Cancer Research, and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA, USA
- 3Department of Pathology, Harvard Medical School, Boston, MA, USA
- 4Department of Molecular Engineering, Corteva Agriscience™, Johnston IA, 50131, USA
- 5Cell Design Institute and Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA
- 6Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, USA
- 7Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
- 8Chan Zuckerberg Biohub, San Francisco, CA, USA
- 9Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA
- ↵†Corresponding author. Email: khalil{at}bu.edu (A.S.K.)
↵* These authors contributed equally to this work.
Posted June 07, 2021.
